Inclusion Criteria :  Patients will only be included in the study if they meet all of the following criteria :  -  Patient who has given informed consent  -  Patient with age 18 years or older  -  Patient with locally or distantly advanced breast carcinoma , with at least 1 lesion of at least 12 mm maximal diameter . For lymph node metastases , the largest diameter should be at least 15 mm and the short axis at least 12 mm .  Exclusion Criteria :  Patients will not be included in the study if one or more of the following criteria  applies :  -  Patient is pregnant  -  Patient is breast feeding  -  Patient with recent (  < 1 week ) gastrointestinal disorders with diarrhea as major symptom  -  Patient with any serious active infection  -  Patient who has any other life - threatening illness or organ system dysfunction , which in the opinion of the investigator would either compromise patient safety or interfere with the evaluation of the test radiopharmaceutical  -  Patient who can not communicate reliably with the investigator  -  Patient who is unlikely to cooperate with the requirements of the study  -  Patient who is unwilling and / or unable to give informed consent  -  Patient at increased risk of death from a pre - existing concurrent illness  -  Patient who participated already in this study . 